Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-13 Kewalramani Reshma CEO & President Shares withheld for taxes −5,990 $298.26 $1.8M 148,714
2023-02-13 Bozic Carmen EVP and CMO Shares withheld for taxes −4,992 $298.26 $1.5M 70,265
2023-02-13 Arbuckle Stuart A EVP, COO Shares withheld for taxes −5,990 $298.26 $1.8M 86,890
2023-02-13 Arbuckle Stuart A EVP, COO Sale −245 $296.44 $73K 86,645
2023-02-13 Arbuckle Stuart A EVP, COO Sale −2,028 $298.42 $605K 84,617
2023-02-13 Arbuckle Stuart A EVP, COO Sale −1,779 $299.26 $532K 82,838
2023-02-13 Arbuckle Stuart A EVP, COO Sale −835 $300.13 $251K 82,003
2023-02-13 ALTSHULER DAVID EVP, Global Research and CSO Shares withheld for taxes −5,990 $298.26 $1.8M 59,194
2023-02-13 ALTSHULER DAVID EVP, Global Research and CSO Sale −245 $296.44 $73K 58,949
2023-02-13 ALTSHULER DAVID EVP, Global Research and CSO Sale −2,160 $298.47 $645K 56,789
2023-02-13 ALTSHULER DAVID EVP, Global Research and CSO Sale −1,893 $299.36 $567K 54,896
2023-02-13 ALTSHULER DAVID EVP, Global Research and CSO Sale −500 $300.23 $150K 54,396
2023-02-10 WAGNER CHARLES F JR EVP & Chief Financial Officer Shares withheld for taxes −2,707 $294.33 $797K 70,183
2023-02-10 Tatsis Ourania EVP, Chief Reg. & Quality Off. Shares withheld for taxes −1,377 $294.33 $405K 69,035
2023-02-10 Sanna Bastiano EVP, Cell & Genetic Therapies Shares withheld for taxes −902 $294.33 $265K 66,368
2023-02-10 Sachdev Amit EVP, Chief Patient Officer Shares withheld for taxes −2,611 $294.33 $768K 77,141
2023-02-10 Kewalramani Reshma CEO & President Shares withheld for taxes −3,372 $294.33 $992K 154,704
2023-02-10 Bozic Carmen EVP and CMO Shares withheld for taxes −2,707 $294.33 $797K 75,257
2023-02-10 Arbuckle Stuart A EVP, COO Shares withheld for taxes −3,372 $294.33 $992K 92,880
2023-02-10 ALTSHULER DAVID EVP, Global Research and CSO Shares withheld for taxes −3,461 $294.33 $1.0M 65,184

Page 37 of 40 · 781 trades